Baseline characteristics of lesions in subjects with leishmaniasis treated with imiquimod 5% cream plus pentavalent antimony versus placebo plus pentavalent antimony, participating in a randomized trial, Peru, 2006�C7.

Baseline characteristics of lesions in subjects with leishmaniasis treated with imiquimod 5% cream plus pentavalent antimony versus placebo plus pentavalent antimony, participating in a randomized trial, Peru, 2006�C7.本数据集涵盖2006至2007年秘鲁一项随机试验中，接受5%咪喹莫特乳膏（imiquimod 5% cream）联合五价锑（pentavalent antimony）治疗，与接受安慰剂（placebo）联合五价锑（pentavalent antimony）治疗的利什曼病（leishmaniasis）受试者的皮损基线特征。